KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Interest & Investment Income: 2011-2025

Historic Interest & Investment Income for Idexx Laboratories (IDXX) over the last 15 years, with Sep 2025 value amounting to $580,000.

  • Idexx Laboratories' Interest & Investment Income fell 78.63% to $580,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year decrease of 67.29%. This contributed to the annual value of $12.7 million for FY2024, which is 125.60% up from last year.
  • Idexx Laboratories' Interest & Investment Income amounted to $580,000 in Q3 2025, which was down 7.50% from $627,000 recorded in Q2 2025.
  • Idexx Laboratories' Interest & Investment Income's 5-year high stood at $4.4 million during Q1 2024, with a 5-year trough of $52,000 in Q1 2021.
  • Moreover, its 3-year median value for Interest & Investment Income was $1.3 million (2023), whereas its average is $1.9 million.
  • Per our database at Business Quant, Idexx Laboratories' Interest & Investment Income surged by 1,445.11% in 2023 and then slumped by 81.31% in 2025.
  • Quarterly analysis of 5 years shows Idexx Laboratories' Interest & Investment Income stood at $169,000 in 2021, then skyrocketed by 39.05% to $235,000 in 2022, then spiked by 1,445.11% to $3.6 million in 2023, then crashed by 39.44% to $2.2 million in 2024, then crashed by 78.63% to $580,000 in 2025.
  • Its last three reported values are $580,000 in Q3 2025, $627,000 for Q2 2025, and $1.2 million during Q1 2025.